We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAMI
1001
Acadian Asset Management
AAMI
$3.08B
$737K 0.01%
51,700
+33,100
+178% +$507K
SLCT
1002
DELISTED
Select Bancorp, Inc.
SLCT
$736K 0.01%
54,676
FLNT
1003
Fluent
FLNT
$102M
$735K 0.01%
50,000
+37,733
+308% +$615K
MNKD icon
1004
MannKind Corp
MNKD
$1.21B
$735K 0.01%
387,000
+335,000
+644% +$627K
DRNA
1005
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$735K 0.01%
60,000
-23,300
-28% -$293K
KMG
1006
DELISTED
KMG Chemicals Inc
KMG
$730K 0.01%
9,900
MLP icon
1007
Maui Land & Pineapple Co
MLP
$344M
$727K 0.01%
64,867
+33,000
+104% +$375K
CHFN
1008
DELISTED
Charter Financial Corp
CHFN
$725K 0.01%
30,000
UFI icon
1009
UNIFI
UFI
$119M
$720K 0.01%
22,700
OTIC
1010
DELISTED
Otonomy, Inc.
OTIC
$714K 0.01%
+185,500
New +$772K
OLBK
1011
DELISTED
Old Line Bancshares, Inc.
OLBK
$714K 0.01%
+20,440
New +$700K
OPCH icon
1012
Option Care Health
OPCH
$3.45B
$712K 0.01%
60,725
+12,500
+26% +$131K
FSBW icon
1013
FS Bancorp
FSBW
$319M
$708K 0.01%
22,400
CALA
1014
DELISTED
Calithera Biosciences, Inc
CALA
$707K 0.01%
7,070
GPIC
1015
DELISTED
Gaming Partners International Corporation
GPIC
$705K 0.01%
82,367
HOFT icon
1016
Hooker Furnishings Corp
HOFT
$150M
$704K 0.01%
15,000
-15,000
-50% -$614K
KAI icon
1017
Kadant
KAI
$3.63B
$702K 0.01%
7,300
+4,900
+204% +$471K
EXTR icon
1018
Extreme Networks
EXTR
$3.94B
$700K 0.01%
88,000
+32,000
+57% +$307K
PRSU
1019
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
$700K 0.01%
12,894
HABT
1020
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$700K 0.01%
70,000
OCUL icon
1021
Ocular Therapeutix
OCUL
$1.79B
$697K 0.01%
103,300
TBRG
1022
DELISTED
TruBridge
TBRG
$697K 0.01%
+21,200
New +$666K
INAP
1023
DELISTED
Internap Corporation
INAP
$696K 0.01%
+66,800
New +$761K
MCHX icon
1024
Marchex
MCHX
$76.2M
$695K 0.01%
227,000
PETX
1025
DELISTED
Aratana Therapeutics, Inc.
PETX
$692K 0.01%
162,783

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.